Ticlopidine Aspirin Stroke Study

Completed

Phase N/A Results

Eligibility Criteria

Inclusion Criteria

One or more of the following within 3 months of entry: transient ischemic attack (a focal ischemic cerebrovascular event lasting less than 24 hours and followed by complete recovery); amaurosis fugax (a unilateral ischemic retinal episode lasting less than 24 hours); reversible ischemic neurologic deficit (a focal ischemic cerebrovascular event lasting more than 24 hours but less than three weeks and followed by complete recovery); minor stroke (a focal ischemic cerebrovascular event resulting in minimal permanent neurologic deficit and at least 80 % recovery of function within 3 weeks).

Exclusion Criteria

Women with childbearing potential; symptoms due to migraine, cardiogenic embolism, or hematologic disorders; history of peptic ulcer disease, upper gastrointestinal bleeding, or life-threatening diseases such as cancer; previous hypersensitivity or intolerance to aspirin; need for continued use of aspirin or anticoagulants.